Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company provides pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Abbott Laboratories

Abitare In SpA ( ($IT:ABT) ) has provided an announcement. Abitare In S.p.A., the Milan-based residential developer listed on the Euronext STAR Mil...

Abitare In Publishes Shareholders’ Meeting Voting Summary

Dividend ETFs remain a go-to choice for investors seeking steady income. Two leading choices are the Schwab U.S. Dividend Equity ETF ($SCHD) and th...

VYMI vs. SCHD: Which Is the Best Dividend ETF for Passive Income?

Lakewood-Amedex Biotherapeutics stock soared after the company reported that Nu-3 showed a high barrier to resistance in lab tests.


Why Is Penny Stock Lakewood-Amedex Biotherapeutics (LABT) Up Today?

In a report released on July 17, Jayson Bedford from Raymond James maintained a Buy rating on Abbott Laboratories. The company’s shares closed last...

Abbott Laboratories (ABT) Gets a Buy from Raymond James

Jefferies analyst reiterated a Buy rating on Abbott Laboratories today and set a price target of $135.00. In a report released today, Citi also mai...

Jefferies Reaffirms Their Buy Rating on Abbott Laboratories (ABT)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Intuitive Surgical (ISRG), Abbott Laboratories (ABT)...

Analysts Are Bullish on Top Healthcare Stocks: Intuitive Surgical (ISRG), Abbott Laboratories (ABT)

Abbott Laboratories stock took off on Thursday after the company posted strong earnings and updated its EPS guidance.


Abbott Laboratories Stock (ABT) Rallies on a Q2 Earnings Beat and a 2026 EPS Guidance Increase

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Alpha Tau Medical Ltd (DRTS) and Abbott Laboratories...

Analysts’ Top Healthcare Picks: Alpha Tau Medical Ltd (DRTS), Abbott Laboratories (ABT)

In a report released today, Josh Jennings from TD Cowen reiterated a Buy rating on Abbott Laboratories, with a price target of $115.00. According t...

TD Cowen Sticks to Its Buy Rating for Abbott Laboratories (ABT)

In a report released yesterday, Travis Steed from Bank of America Securities maintained a Buy rating on Abbott Laboratories, with a price target of...

Abbott Laboratories (ABT) Receives a Buy from Bank of America Securities

RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Abbott Laboratories yesterday and set a price target of $130.00. Singh Chadha co...

RBC Capital Sticks to Its Buy Rating for Abbott Laboratories (ABT)

Stocks ended the week higher as continued enthusiasm for AI and technology shares helped lift the major U.S. indexes. The Dow Jones Industrial Aver...

The Week That Was, The Week Ahead: Macro and Markets, July 12

AbbVie ($ABBV) and Abbott Laboratories ($ABT) are two Dividend Aristocrat stocks with a Strong Buy consensus rating on Wall Street and an ex-divide...

2 ‘Strong Buy’ Dividend Aristocrat Stocks to Grab Right Now for August Payouts

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Resmed (RMD), Abbott Laboratories (ABT) and Vera T...

Analysts Offer Insights on Healthcare Companies: Resmed (RMD), Abbott Laboratories (ABT) and Vera Therapeutics (VERA)

Citi analyst Joanne Wuensch reiterated a Buy rating on Abbott Laboratories on July 6 and set a price target of $108.00. The company’s shares closed...

Citi Keeps Their Buy Rating on Abbott Laboratories (ABT)

Retail investors have jumped on board airline Delta Air Lines ($DAL) ahead of its Q2 earnings report later this week – July 10th. DAL, despite bein...

Retail Investors Jump On Board DAL Stock Ahead of Q2 Earnings

American Bitcoin Corp ( ($ABTC) ) just unveiled an announcement. On July 2, 2026, American Bitcoin Corp. implemented a 1-for-15 reverse stock split...

American Bitcoin Corp executes reverse stock split initiative

Let’s take a look at the upcoming stock splits for the week of July 6 to July 10, based on TipRanks’ Stock Splits Calendar. A stock split can say a...

Upcoming Stock Splits This Week (July 6 to July 10) – Stay Invested

Analysts are intrested in these 5 stocks: ( ($FWDI) ), ( ($AVAV) ), ( ($ABT) ), ( ($SPG) ) and ( ($TALO) ). Here is a breakdown of their recent


Forward, AVAV, Abbott, SPG, Talos Trending With Analysts

Abbott Laboratories ($ABT), Nucor ($NUE), and Coca-Cola ($KO) are the three dividend aristocrat stocks with a Strong Buy rating on Wall Street, acc...

3 Dividend Aristocrat Stocks Wall Street Loves Right Now — June 30, 2026

Abbott Laboratories ($ABT), Cintas ($CTAS), and McDonald’s ($MCD) are three dividend aristocrat stocks offering more than 20% upside potential, acc...

3 Dividend Aristocrat Stocks with 20%+ Upside — June 25, 2026

American Bitcoin Corp ( ($ABTC) ) has issued an announcement. On June 22, 2026, American Bitcoin Corp. held its 2026 Annual Meeting of Stockholders...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	ABT	$103.06	+2.29%	10.37M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	ABT	$103.06	+2.3%	10.37M
3
4
5
6

ABT

ABT

Get Abbott Laboratories Data in Excel

Get Abbott Laboratories Data in Excel